Kiora Pharmaceuticals Market Risk Adjusted Performance
| KPRX Stock | | | USD 2.04 -0.05 -2.39% |
The Market Risk Adjusted Performance indicator for Kiora Pharmaceuticals is constructed from normalized market data. The depth of trading history affects the precision of the indicator. Kiora Pharmaceuticals has a market cap of 7.69 M, current ratio of 1.53. Review
Correlation Analysis for a broader allocation view. Monitoring Kiora Pharmaceuticals within a portfolio highlights how it interacts with other holdings. The dataset reflects available inputs without directional implication. Broader economic conditions can influence Kiora Pharmaceuticals's company valuation — related indicators include
signals in real.
Our
How to Trade Kiora Pharmaceuticals guide. The guide covers key considerations relevant to Kiora Stock order placement. It provides context that complements the data on this page for Kiora Pharmaceuticals.
Kiora Pharmaceuticals has current Market Risk Adjusted Performance of 0.0615.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | 0.0615 | |
| ER[a] | = | Expected return on investing in Kiora Pharmaceuticals |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
Market Risk Adjusted Performance Peers Comparison
Market Risk Adjusted Performance Relative To Other Indicators
Kiora Pharmaceuticals is rated
fourth in market risk adjusted performance among leading competitors. It is currently under evaluation in maximum drawdown among leading competitors reporting about
201.06 of Maximum Drawdown per Market Risk Adjusted Performance. At
201.07 , Kiora Pharmaceuticals's Maximum Drawdown-to-Market Risk Adjusted Performance multiple reflects the spread between these metrics
Other Technical Indicators